DJIA 17,077.38 -36.16 -0.21%
NASDAQ 4,471.57 15.55 0.35%
S&P 500 1,985.17 1.64 0.08%
market minute promo

InterMune (NASDAQ: ITMN)

46.75 1.61 (3.57%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ITMN $46.75 3.57%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $45.49
Previous Close $45.14
Daily Range $45.29 - $47.72
52-Week Range $10.95 - $47.72
Market Cap $4.6B
P/E Ratio -17.10
Dividend (Yield) $0.00 (0.0%)
Volume 1,509,109
Average Daily Volume 1,875,077
Current FY EPS -$2.31

Sector

Healthcare

Industry

Drugs

InterMune (ITMN) Description

The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology. Website: http://www.intermune.com/

News & Commentary Rss Feed

InterMune Inc. ASCENDs to Greatness

InterMune succeeds where Gilead and Novartis failed. Its IPF drug Esbriet looks destined for approval.

Edelman's Perceptive Advisors Buying Amicus Therapeutics Ahead Of Phase III Data Release

InterMune's (ITMN) Esbriet Gets Breakthrough Designation - Analyst Blog

Why InterMune (ITMN) Might Surprise This Earnings Season - Tale of the Tape

IWM, FNY: Big ETF Outflows

Use Options For a Chance To Buy InterMune at a 42% Discount

4 Biotech Stocks Worth A Look Ahead Of FDA Approvals

The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher

3 Hot Biotech Stocks Hitting Highs

Today In SA PRO: Friday, June 13

InterMune's A Strong Buy As Esbriet Finally Has The Data Physicians, Patients, And FDA Have Longed F

InterMune's A Strong Buy As Esbriet Finally Has The Data Physicians, Patients, And FDA Have Longed For

See More ITMN News...

ITMN's Top Competitors

ITMN $46.75 (3.57%)
Current stock: ITMN
GILD $89.55 (0.25%)
Current stock: GILD
CELG $88.64 (2.29%)
Current stock: CELG
AMGN $121.30 (0.16%)
Current stock: AMGN